OvaPrint - a novel cfDNA methylation liquid biopsy for cancer risk assessment in high grade serous ovarian carcinoma

被引：0
|
作者：
Buckley, David N.
Gooden, Gerald
Shulman, Lee
Newman, Monica
Guo, Mona
Tew, Ben Yi
Roman, Lynda
Lewinger, Juan Pablo
Salhia, Bodour
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-1025
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1025
引用
收藏
页数：2
相关论文
共 50 条
  • [1] OvaPrint-A Cell-free DNA Methylation Liquid Biopsy for the Risk Assessment of High-grade Serous Ovarian Cancer
    Buckley, David N.
    Lewinger, Juan Pablo
    Gooden, Gerald
    Spillman, Monique
    Neuman, Monica
    Guo, X. Mona
    Tew, Ben Yi
    Miller, Heather
    Khetan, Varun U.
    Shulman, Lee P.
    Roman, Lynda
    Salhia, Bodour
    CLINICAL CANCER RESEARCH, 2023, 29 (24) : 5196 - 5206
  • [2] OvaPrintTM - a novel cfDNA methylation liquid biopsy for cancer risk assessment in epithelial ovarian cancer
    Buckley, David N.
    Lewinger, Juan Pablo
    Gooden, Gerald
    Spillman, Monique
    Neuman, Monica
    Guo, Mona
    Tew, Ben Y.
    Miller, Heather
    Khetan, Varun U.
    Shulman, Lee P.
    Roman, Lynda
    Salhia, Bodour
    CANCER RESEARCH, 2024, 84 (05)
  • [3] ESR1 methylation in plasma cfDNA of patients with high-grade serous ovarian cancer
    Giannopoulou, Lydia
    Mastoraki, Sophia
    Strati, Areti
    Chebouti, Isaam
    Kasimir-Bauer, Sabine
    Lianidou, Evi S.
    CANCER RESEARCH, 2017, 77
  • [4] Characterizing dynamic landscape of DNA methylation in ovarian high-grade serous carcinoma
    Lahtinen, Alexandra
    Marchi, Giovanni
    Afenteva, Daria
    Holmstrom, Susanna
    Huhtinen, Kaisa
    Virtanen, Anni
    Hynninen, Johanna
    Hakkinen, Antti
    Hautaniemi, Sampsa
    CANCER RESEARCH, 2023, 83 (07)
  • [5] Utility of ovarian biopsy in pancreatic metastasis of high-grade serous ovarian carcinoma: A case report
    Nakamura, Kohei
    Nakayama, Kentaro
    Ishikawa, Masako
    Ishikawa, Noriyoshi
    Nagase, Mamiko
    Katagiri, Hiroshi
    Ishibashi, Tomoka
    Sato, Emi
    Iida, Kohji
    Sultana, Razia
    Kyo, Satoru
    MOLECULAR AND CLINICAL ONCOLOGY, 2016, 5 (01) : 41 - 43
  • [6] Novel strategies for targeting high-grade serous ovarian cancer
    Perets, Ruth
    Wyant, Gregory A.
    Ohman, Anders W.
    Setlur, Sunita R.
    Crum, Christopher P.
    Drapkin, Ronny
    Dinulescu, Daniela M.
    CLINICAL CANCER RESEARCH, 2015, 21
  • [7] Identification of Novel Fusion Transcripts in High Grade Serous Ovarian Cancer
    Newtson, Andreea
    Reyes, Henry
    Devor, Eric J.
    Goodheart, Michael J.
    Bosquet, Jesus Gonzalez
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (09)
  • [8] Frequency of serous tubal intraepithelial carcinoma (STIC) in patients with high grade serous ovarian cancer
    Byun, Jung Mi
    Cho, Hwa Jin
    Lee, Dae Sim
    Yoon, Hye Kyoung
    Kim, Young Nam
    Im, Do Hwa
    Kim, Da Hyun
    Lee, Kyung Bok
    Sung, Moon Su
    Jeong, Dae Hoon
    TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2023, 62 (01): : 107 - 111
  • [9] No evidence for PALB2 methylation in high-grade serous ovarian cancer
    Thomas Mikeska
    Kathryn Alsop
    Gillian Mitchell
    David DL Bowtell
    Alexander Dobrovic
    Journal of Ovarian Research, 6
  • [10] Prognostic and diagnostic significance of DNA methylation patterns in high grade serous ovarian cancer
    Montavon, Celine
    Gloss, Brian S.
    Warton, Kristina
    Barton, Caroline A.
    Statham, Aaron L.
    Scurry, James P.
    Tabor, Bruce
    Nguyen, Tuan V.
    Qu, Wenja
    Samimi, Goli
    Hacker, Neville F.
    Sutherland, Robert L.
    Clark, Susan J.
    O'Brien, Philippa M.
    GYNECOLOGIC ONCOLOGY, 2012, 124 (03) : 582 - 588
12345